Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2020-03-01
2021-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Using High-flow Nasal Oxygen-delivery System in Patients Under Intravenous General Anesthesia
NCT03019354
Standard Oxygen Versus High Flow Nasal Cannula Oxygen Therapy in Patients With Acute Hypoxemic Respiratory Failure
NCT04468126
The Effect of High-flow Nasal Oxygen Flow Rate on Gas Exchange During Apnoea
NCT05124093
Oxygenation by 100% Oxygen Via High Flow Nasal Cannula in Surgical Patients
NCT02706431
Flow Rates of High-flow Nasal Cannula and Extubation Outcome
NCT04934163
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The participants after fulfilling the eligibility criteria will be randomly assigned to the respective arm (High Flow, Low Flow or Standard). For procedure, depending upon the arm, the head side of the patient bed will be elevated up to 30 degrees in order to better visualize the glottis. The participants in the high flow oxygen delivery through nasal cannula preoxygenation will be set for 4 min at 6 L/min through humidified and heated pure oxygen (fraction of inspired oxygen 100%, 37C). Similarly, participant in the low flow oxygen delivery through nasal cannula preoxygenation will be set for 4 min at 3 L/min through humidified and heated pure oxygen (faction of inspired oxygen 100%, 37C). Throughout the procedure the high flow nasal cannula or low flow nasal cannula will be maintained trying to achieve a continuous oxygen during direct laryngoscopy for RSI.
Standard Arm:
In the standard arm the head end of the bed will not be raised to 30 degrees instead the whole bed is raised up to the operator belly button in order to ease glottis visualization. In the standard group the preoxygenation is for 4 min or till achievement of peripheral oxygen saturation greater than 95% with a face mask that will be connected to the oxygen port at 10 L/min. During the direct laryngoscopy there will be no insufflation of oxygen through nasal cannula or face mask.
Data collection:
Research staff involved in collecting data, will be independent from primary research team in order to minimize observer bias. The oxygen saturations will be recorded using pulse oximetry (through a standard infrared oximetry tape) exclusively used for research purpose and will record time using stop watch (Casio Digital Stop Watch) during and after the procedure. The operator will report research staff about all subjective assessments of difficult intubation and airway complications during procedure on the data collection tool. The operator while performing the direct laryngoscopy, if experience difficulty as per Corkman Lehman grade, will inform research staff for protocol deviation.
Intubation attempts (number of time laryngoscope blade placed in the mouth) will be counted for each patient. In those patients where first pass is failed and subsequent attempt is made without assisted ventilation, the apnea time will be noted as mentioned above. To confirm the accuracy of data collected, the investigators will conduct a concurrent assessment of the outcomes for a convenience sample of 10% of enrolled participants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High flow oxygen delivery
Oxygen delivery with high flow nasal cannula with head side elevation to 30 degrees
High flow nasal cannula oxygen delivery
It includes the delivery of oxygen through a high flow nasal cannula with head side elevation to 30 degrees to prevent desaturation and improve first pass success rate of endotracheal intubation
Low Flow oxygen delivery
Low flow oxygen delivery through nasal cannula with head side elevation to 30 degrees
Low flow nasal cannula oxygen delivery
It includes the delivery of oxygen through a low flow nasal cannula coupled with head side elevation to 30 degrees to prevent desaturation and improve first pass success rate of endotracheal intubation
Standard practice of care
No oxygen delivery either high flow or low flow through nasal cannula
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High flow nasal cannula oxygen delivery
It includes the delivery of oxygen through a high flow nasal cannula with head side elevation to 30 degrees to prevent desaturation and improve first pass success rate of endotracheal intubation
Low flow nasal cannula oxygen delivery
It includes the delivery of oxygen through a low flow nasal cannula coupled with head side elevation to 30 degrees to prevent desaturation and improve first pass success rate of endotracheal intubation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Intubation performed by the emergency medicine physician who are post graduate trainee year IV and above. The year IV and above cut off is taken because at this time the trainees have done more than 20 endotracheal intubations. The operators are assessed through direct supervision and confirmation through filing of their procedural log books
Exclusion Criteria
2. Patients presenting with cardiac arrest
3. Pregnant patients (as the patients are at risk of aspiration and high oxygen delivery can have bad outcomes on the fetus)
4. Patients with 'Do not resuscitate' order.
5. Morbidly obese on assessment as such patient may need pre intubation preparation of the head side and more controlled settings.
6. Patient who are shifted from another hospital post intubation
7. Patients with interstitial lung disease or lung tumor
8. Neck trauma (expanding neck hematoma)
9. Neck and Oral cavity cancers, or patients with cancers of the neck and oral cavity who have undergone surgery, post radiation of the neck and oral cavity cancers.
10. Pulse oximetry \<90% in ambient air.
11. Body mass index \> 35kg/m2
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aga Khan University Hospital, Pakistan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shahan Waheed
Principal investigator and Consultant Emergency Medicine
References
Explore related publications, articles, or registry entries linked to this study.
Waheed S, Kapadia NN, Jawed DR, Raheem A, Khan MF. Randomized controlled trial to assess the effectiveness of apnoeic oxygenation in adults using a low-flow or high-flow nasal cannula with head side elevation during endotracheal intubation in the emergency department. BMC Res Notes. 2025 Jul 1;18(1):264. doi: 10.1186/s13104-025-07328-7.
Waheed S, Kapadia NN, Khan MF, Kerai SM, Raheem A, Naeem R. Randomised controlled trial to assess the effectiveness of apnoeic oxygenation in adults using low-flow or high-flow nasal cannula with head side elevation versus usual care to prevent desaturation during endotracheal intubation in the emergency department (ApOxED): study protocol. BMJ Open. 2020 Nov 16;10(11):e037964. doi: 10.1136/bmjopen-2020-037964.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
192002ER-PK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.